Abstract: Provided is a compound or a pharmaceutically acceptable salt, prodrug, or metabolite thereof, or a solvate or hydrate of any of the foregoing and a use in treatment of a disease or disorder.
Abstract: The present disclosure provides substituted heteroaryl compounds and use thereof, also provides compounds or pharmaceutically acceptable salts or solvates thereof as PAD inhibitors and their use in treatment of a disease or disorder.
Type:
Application
Filed:
October 11, 2021
Publication date:
November 30, 2023
Applicant:
HELIOS HUAMING BIOPHARMA CO., LTD.
Inventors:
Yanming WANG, Yan XIA, Jinquan SUN, Mingde XIA